Cyclo (CLLFVY)
Cyclo (CLLFVY) is an inhibitor for hypoxia inducible factor-1 (HIF-1), with IC50 of 19 μM (in U2OS) and 16 μM (in MCF-7) . cyclo (CLLFVY) binds to the PAS-B domain of HIF-1α, inhibits HIF-1 dimerization and transcriptional activity. cyclo (CLLFVY) downregulates the expression of hypoxia response genes, such as VEGF and CAIX, exhibits antitumor against the HIF-1 associated cancers[1].
Product Specifications
CAS Number
[1446322-73-1]
UNSPSC
12352209
Target
HIF/HIF Prolyl-Hydroxylase; VEGFR
Type
Peptides
Related Pathways
Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cyclo-cllfvy.html
Purity
99.37
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](C(C)C)C(N[C@H]2CC3=CC=C(C=C3)O)=O)=O)=O)=O)[C@H](CS)NC2=O
Molecular Formula
C38H54N6O7S
Molecular Weight
738.94
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P10426/cyclo-CLLFVY-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P10426/cyclo-CLLFVY-SDS-MedChemExpress.pdf
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
SARS-CoV-2 Recombinant Antigen Spike Protein, S2 Subunit, His-tag
SARS-CoV-2 Recombinant Antigen Spike Protein, S2 Subunit, His-tag
